Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 6Colorectal Neoplasms 5Neoplasms 4Stomach Neoplasms 3Malnutrition 3Lung Neoplasms 3Diarrhea 3Uterine Cervical Neoplasms 2Mucositis 2Inflammation 2Enteritis 2Chalazion 2Carcinoma, Hepatocellular 2Thyroid Neoplasms 1Squamous Intraepithelial Lesions 1Smoldering Multiple Myeloma 1Radiation Injuries 1Psychological Well-Being 1Psoriasis Vulgaris 1Polycystic Ovary Syndrome 1Periampullary Carcinoma Nos 1Pelvic Neoplasms 1Pelvic Inflammatory Disease 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Muscle Invasive Bladder Cancer (MIBC) 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1

Interventions

VGX-3100 4Light Coagulation 3DNA Methylation 3Colposcopy 3Biopsy 3Watchful Waiting 2Polymerase Chain Reaction 2Observation 2Laser Therapy 2Imiquimod 2Fluorouracil 2Electroporation 2Cidofovir 2Aminolevulinic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2epigallocatechin gallate 1calcipotriene 1Solutions 1Restraint, Physical 1Red Light 1Radiofrequency Ablation 1Probiotics 1Mindfulness-Based Stress Reduction 1Megestrol Acetate 1Mass Screening 1Immunohistochemistry 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Human Papillomavirus DNA Tests 1Histological Techniques 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Intraepithelial Lesions × Probiotics × Clear all
NCT06949800 2026-05-01

CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

University of California, San Francisco

Phase 2 Not yet recruiting
90 enrolled
Gynecologic

Squamous Intraepithelial Lesions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡